WH Smith won't be left on the shelf

MERGER fever may have gripped the stock market, but it seems to have passed by the retail sector, with the exception of the Unichem bid for Lloyds Chemists, now kicked into touch by the OFT.

Stores guru Nick Bubb, at Dutch stockbroker Mees Pierson, has been working out the relative attractions to a bidder of two of the sector's big disappointments, WH Smith and Sears. WH Smith, he believes, wins hands down as the more attractive of the two.

Both groups own plum assets - Selfridges in the case of Sears, and Virgin, Our Price and Waterstones for the newsagent. Both also have problem areas - Do-It-All for W H Smith, British Shoe Corporation at Sears.

But WH Smith probably offers a bidder more in terms of brand strength, market share and complementary businesses.

Smith, says Mr Bubb, is a buy and Sears, at 99.5p, a sell. The latter is likely to see profits decline further to pounds 100m in 1995 to 1996, to leave the shares on an overdemanding p/e ratio of 20.

Recovery at W H Smith, however, could lift the shares, at 421p, in any case, while a radical review to be unveiled in May could provide another fillip.

GUINNESS reports preliminary figures for 1995 this week and the market expects a good performance, despite a renewed bout of exceptional items that will hold profits back somewhat.

As a result, forecasts Dermott Carr of Nikko Europe, pre-tax profits will fall to pounds 896m from pounds 915m in 1994. However, that will leave the shares on an attractive 4.1 per cent yield.

There is also a growing belief that the company, still spinning off cash, will buy back its shares, or attempt in some way to return cash to shareholders. The shares, on 4671/2p, trade at around 13 times 1996's estimated pre- tax profit of pounds 1bn. Buy for the long term.

WHEN we tipped Flomeric here last December at 205p, its shares had only just been floated on the Alternative Investment Market at 130p. They have not moved since.

Management concerns of a slowdown in profit growth at the software supplier for fluid flow and heat transfer control proved misplaced. A pre-tax profit of pounds 415,565 was well ahead of the pounds 400,000 forecast at the time of flotation.

Sales also continued their impressive growth, up 33 per cent to pounds 4.147m. The company is paying its first dividend, 2.6p, and the cash surplus grew slightly to pounds 664,238.

The directors remain confident they can maintain the gross margins of around 90 per cent, which are not uncommon to software firms, and see a rosy future. Buy.

CORTECS (269p), the biotech start-up, continues to make significant progress on the research and development front, as its interim figures last week demonstrated.

For those of us who are able to withstand the nervous tension of possessing high-risk shares, the outlook remains promising.

Research and development of pounds 2.5m was the same as the previous six months, but growing sales for its diagnostic product, Helisal, reduced the cash burn to pounds 1.6m from pounds 2.2m.

Chairman Glen Travers hopes to launch a "one-step" blood test as well as a saliva test for Helicobacter pylori - the bacteria which is associated with stomach ulcers. The company is also collaborating on an oral treatment for eradicating H pylori.

Its osteoporosis diagnostic Osteosal should be launched on the European market some time later this year.

The company also has a product on the books that could lead to an oral version of insulin for diabetics. The shares remain a buy.

WHAT IS up at Signet, the jewellery group, once the fiefdom of Gerald Ratner?

In the past week, the shares have risen sharply to 231/2p. Volumes, by normal standards, have been heavy.

A buyer could be just around the corner for the group's British businesses, H Samuel and Ernest Jones. An information memorandum recently sent out to interested parties may have prompted the recent gains. Some comfort to long-suffering shareholders, perhaps, but there is little incentive to invest at this time.

If a deal goes through, it will leave a peculiar beast: most of the business will be in the US, while the shares are listed over here - another problem that will have to be rectified in due course. The shares are best left alone. Avoid.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Digital Optimisation Executive - Marketing

£30000 - £35000 per annum: Recruitment Genius: The UK's fastest growing, multi...

Recruitment Genius: Financial Reporting Manager

£70000 - £90000 per annum: Recruitment Genius: A Financial Reporting Manager i...

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Day In a Page

Sepp Blatter resignation: The beginning of Fifa's long road to reform?

Does Blatter's departure mean Fifa will automatically clean up its act?

Don't bet on it, says Tom Peck
Charles Kennedy: The baby of the House who grew into a Lib Dem giant

The baby of the House who grew into a Lib Dem giant

Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

The harrowing testament of a five-year-old victim of Syria's endless civil war

Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
The future of songwriting: How streaming is changing everything we know about making music

The future of songwriting

How streaming is changing everything we know about making music
William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

Recognition at long last

Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
Beating obesity: The new pacemaker which helps over-eaters

Beating obesity

The new pacemaker which helps over-eaters
9 best women's festival waterproofs

Ready for rain: 9 best women's festival waterproofs

These are the macs to keep your denim dry and your hair frizz-free(ish)
Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

Wiggins worried

Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back
Thurston Moore interview

Thurston Moore interview

On living in London, Sonic Youth and musical memoirs
In full bloom

In full bloom

Floral print womenswear
From leading man to Elephant Man, Bradley Cooper is terrific

From leading man to Elephant Man

Bradley Cooper is terrific